These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 24334279

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression.
    Kim HJ, Yoon KA, Lee MK, Kim SH, Lee IK, Kim SY.
    Life Sci; 2012 Nov 02; 91(19-20):928-34. PubMed ID: 23000100
    [Abstract] [Full Text] [Related]

  • 7. A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-κB signaling and blocks cytoskeletal organization and survival in mature osteoclasts.
    Kim HJ, Yoon HJ, Kim SY, Yoon YR.
    Mol Cells; 2014 Aug 02; 37(8):598-604. PubMed ID: 25134536
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
    Tomomura M, Suzuki R, Shirataki Y, Sakagami H, Tamura N, Tomomura A.
    PLoS One; 2015 Aug 02; 10(6):e0130174. PubMed ID: 26083531
    [Abstract] [Full Text] [Related]

  • 10. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.
    Mol Pharmacol; 2010 Jan 02; 77(1):17-25. PubMed ID: 19828731
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling.
    Kim JY, Kim JY, Kim JJ, Oh J, Kim YC, Lee MS.
    Biol Pharm Bull; 2014 Jan 02; 37(2):255-61. PubMed ID: 24492722
    [Abstract] [Full Text] [Related]

  • 13. Pyridone 6, a pan-Janus-activated kinase inhibitor, suppresses osteoclast formation and bone resorption through down-regulation of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand (RANKL)-induced c-Fos and nuclear factor of activated T cells (NFAT) c1 expression.
    Kwak HB, Kim HS, Lee MS, Kim KJ, Choi EY, Choi MK, Kim JJ, Cho HJ, Kim JW, Bae JM, Kim YK, Park BH, Ha H, Chun CH, Oh J.
    Biol Pharm Bull; 2009 Jan 02; 32(1):45-50. PubMed ID: 19122279
    [Abstract] [Full Text] [Related]

  • 14. The tyrosine kinase inhibitor GNF-2 suppresses osteoclast formation and activity.
    Kim HJ, Yoon HJ, Choi JY, Lee IK, Kim SY.
    J Leukoc Biol; 2014 Feb 02; 95(2):337-45. PubMed ID: 24130113
    [Abstract] [Full Text] [Related]

  • 15. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN, Ha H, Lee JH, Jung K, Yang D, Woo KM, Lee ZH.
    Eur J Pharmacol; 2009 Nov 25; 623(1-3):22-9. PubMed ID: 19766111
    [Abstract] [Full Text] [Related]

  • 16. Decursin from Angelica gigas suppresses RANKL-induced osteoclast formation and bone loss.
    Wang X, Zheng T, Kang JH, Li H, Cho H, Jeon R, Ryu JH, Yim M.
    Eur J Pharmacol; 2016 Mar 05; 774():34-42. PubMed ID: 26825541
    [Abstract] [Full Text] [Related]

  • 17. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.
    Biochem Pharmacol; 2013 Sep 15; 86(6):782-90. PubMed ID: 23928189
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK, Kim HJ, Kwak HB, Lee TH, Bang MH, Kim CM, Lee Y, Chung DK, Baek NI, Kim J, Lee ZH, Kim HH.
    Int Immunopharmacol; 2007 Dec 05; 7(12):1507-16. PubMed ID: 17920527
    [Abstract] [Full Text] [Related]

  • 19. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
    Nepal M, Choi HJ, Choi BY, Yang MS, Chae JI, Li L, Soh Y.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):96-104. PubMed ID: 23791609
    [Abstract] [Full Text] [Related]

  • 20. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
    Kim HS, Suh KS, Sul D, Kim BJ, Lee SK, Jung WW.
    Int J Mol Med; 2012 Feb 05; 29(2):169-77. PubMed ID: 22038020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.